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Phosphate depletion arrests progression of chronic renal failure hide-
pendent of protein intake. Following 5/6 nephrectomy, 18 rats were fed
a normal diet. After 30 days, serum creatinine (5Cr), urine protein
excretion and urine volume were increased compared to pre-nephrect-
omy (0.27 0.1 vs. 1.62 0.6 mg/deciliter, 17.0 10.3 vs. 257.6 13.4
mg/24 hr, and 16.6 4.4 vs. 39.2 11.7 ml/24 hr, respectively, all Pc
0.001). At this time, when serum phosphorus (SN) and serum calcium
(SCa2) were normal, the rats were separated into two groups, matched
and paired by body weight and SCr, and housed separately in metabolic
cages. Animals of one group ingested a normal diet supplemented with
dihydroxyaluminum aminoacetate (DHAAA), 15 g%, to induce phos-
phate depletion (PD). The second group ingested the same diet supple-
mented with 7.5% glycine and was the phosphate replete (PR) group.
All rats were pair fed throughout the study to maintain similar caloric,
protein, carbohydrate, vitamin, and mineral intakes. At six weeks after
separation, SN was decreased in PD vs. PR group (2.85 0.8 vs. 6.71
1.2 mg/deciliter, P c 0.001) and SCa2 was increased in the PD group
(11,98 0.7 vs. 10.03 0.7 mg/deciliter, P C 0.001). Urine urea
nitrogen, body weight, and sodium, potassium and solute excretion
were similar between the groups. At six weeks, urine protein, serum
cholesterol, and urine volume were decreased in PD compared to PR
animals (75.4 41.8vs. 296.0 70.5 mg/24 hr, Pc 0.001; 105.5 30.4
vs. 147.6 34.6 mg/deciliter, P c 0.05; and 35.0 5.7 vs. 45.2 7.5
ml124 hr, P C 0.05, respectively). Evidence of significantly greater
progressive renal injury, as assessed by SCr, in the PR group occurred
by the 12th week, and by the 14th week SCr had risen to 2.96 0.8 vs.
1.58 0.3 mg/deciliter, P c 0.01 and creatinine clearance had de-
creased (46.5 47.3 vs. 282.9 66.8 btl/min, PC 0.005). Tissue calcium
content of heart, aorta and kidney was higher in the PR group. At 14
weeeks, histologic examination of renal tissue from PR rats demon-
strated more severe glomerular sclerosis, interstitial inflammation with
fibrosis, and tubular atrophy and dilation compared to the PD group. PD
alone, therefore, exerts a beneficial effect to prevent the progression of
chronic renal failure in the remnant kidney model of the rat.
In 1978 the progression of chronic renal disease in the
remnant kidney was demonstrated to be prevented by the
ingestion of a low phosphate diet [1]. This low phosphate diet
was also subsequently shown to prevent the progression of
experimental glomerulonephritis [20]. In recent years, how-
ever, there have been a series of studies which have supported
a role of protein restriction in prevention of experimental [3—9]
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chronic renal disease. Since the low phosphate diet is associ-
ated with decreased food [10], and thus protein intake, it is
possible that the earlier results demonstrating protection were
actually due to protein rather than to phosphate restriction.
Moreover, since protein restriction may frequently be associ-
ated with diminished food, and thus phosphate intake, a role of
phosphate restriction in these studies has generally not been
excluded [11]. Tn one study, however, phosphate supplementa-
tion of casein-containing, low phosphate diets were used to
avoid concomitant phosphate depletion [12]. While such a study
may implicate protein restriction in preventing the progression
of chronic renal disease, it does not exclude an independent
effect of phosphate restriction as suggested in earlier studies [1,
2].
To address this issue, the present studies were designed to
examine the role of phosphate restriction per se in preventing
the progression of chronic renal failure in the remnant kidney
model in the rat. To avoid alteration in food palatability which
accompanies the use of synthetic low phosphate diets,
dihydroxyaluminum aminoacetate (DHAAA), a more potent
phosphate binder than aluminum hydroxide, was added to
regular rat chow and fed to rats which had been 5/6 nephrecto-
mized. A control group of nephrectomized rats ingested normal
rat chow supplemented with glycine, the amino acid component
of DHAAA. The DHAAA was dissociated into glycine and
aluminum chloride when exposed to a pH similar to that found
in the stomach [13]. Both groups of rats were pair fed to assure
comparable intake of calories, protein, carbohydrate, fat, min-
erals, and vitamins.
Many investigators using the TCN Pharmaceutical low phos-
phate diet have failed to report the absolute amounts of food
ingested by the rats [1, 2, 14] or have noted that such diets are
associated with food consumption that is about 50%ofnormal
[10, 15]. In preliminary studies (Fig. 1), we have confirmed the
observations of Laouari et al [10] that rats ingesting a commer-
cial low phosphate diet eat less food per day than do normal rats
and become markedly anorexic. Our results (Fig. 1) demon-
strate that rats given the same ICN low phosphate diet as was
used in previous studies [1, 2, 14, 15] eat 10 to 11 g/day
compared to 18 to 22 g/day of normal diet (P C 0.001). These
rats also lose approximately 35 g in body wt over 10 days
irrespective of whether the low phosphate diet is or is not
supplemented with exogenous phosphate (Fig. 1); however,
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Fig. 1.Rats ingesting either P04 replete (Pi = 0.45 g%) or P04 deplete(Pi = 0.05 g%) ICN Pharmaceutical low P04 diet for 10 days lose wt.
Incontrast, rats ingesting a normal diet supplemented with DHAAA for
10 days also became P04 deplete but gain weight as do rats ingesting a
normal diet supplemented with glycine (P04 replete). Values are mean
SE.
rats eating normal rat chow supplemented with DHAAA or
glycine gain approximately 25 g in wt over the same 10 day
period. Rats, therefore, eating a DHAAA or glycine supple-
mented diet consume normal amounts of protein; only the
DHAAA group has a fall in serum phosphorous (Fig. 1). The
results of the present study in 5/6 nephrectomized rats indicate
that DHAAA-induced phosphate binding which leads to
hypophosphatemia in the absence of protein restriction in this
model prevents the deterioration in renal function which usually
accompanies the remnant kidney model.
Materials and methods
Male Sprague-Dawley rats weighing between 190 to 250 g
underwent a 2/3 nephrectomy of the left kidney with cauteriza-
tion of the surface of the remaining intact tissue. One week later
a total right nephrectomy was performed. During the subse-
quent 30 day recovery period, all rats were fed a regular diet of
rat chow (Wayne Lab-Blox, Golden K. Feed and Seed,
Longmont, Colorado, USA) ad libitum. After 30 days, the rats
were separated into two groups, matched individually for serum
creatinine (SCr) and body wt and housed in individual meta-
bolic cages. The animals in one group received the regular
laboratory diet supplemented with 15 g% (wt/wt) DHAAA
(Chattem Chemical Co, Chattanooga, Tennessee, USA). The
animals receiving the phosphate binder DHAAA will be re-
ferred to as the phosphate deplete (PD) group. The second
group of animals also received the regular diet which was
supplemented with 7.5 g% glycine, the amino acid component
of DHAAA; 7.5 g% glycine represented the content of glycine
achieved by addition of 15 g% DHAAA to the diet of the PD
group.
Glycine was obtained from J. T. Baker Chemical Corp.
(Phillipsburg, New Jersey, USA) and rats ingesting this diet will
be referred to as the phosphate replete (PR) group. PD rats
received an aliquot of food each day based on the consumption
of the PR diet by their paired rat. Thus, the major difference in
this study between the two groups involved the consumption of
the aluminum phosphate binder. This maneuver assured that
rats in both groups received comparable daily intakes of calo-
ries, fat, protein, carbohydrate, minerals, and vitamins.
Functional studies
Blood samples (500 d) were obtained biweekly from the tail
artery while the rats were lightly anesthetized with ether. The
plasma from these samples was obtained by centrifugation at
2000g for 10 mm and subsequent determination of hematocrit,
SCr, serum calcium (SCa2), serum phosphorus (SPi), choles-
terol, serum triglycerides, and serum albumin were made.
Urinary volumes were measured daily although measurements
of urine concentrations of protein, sodium, potassium, osmolal-
ity, urea nitrogen, calcium, and phosphorus were only deter-
mined at biweekly intervals. At the end of this study (i.e., 14
weeks post-separation), calcium content of heart, aorta and
kidney was determined by atomic absorption spectroscopy
techniques. The scarred renal tissue, which remained after
cauterization, was dissected free from the underlying but more
normal tissue; the latter was used for calcium analysis.
Bloodpressure, inulin clearance and morphology
Mean arterial pressure (MAP) was also measured biweekly
from the 6th to the 14th week with the same needle in the tail
artery as was used to obtain plasma samples. This needle was
connected to a Statham transducer (Statham Laboratories,
Hato Rey, Puerto Rico) and MAP was recorded on a Gilson
polygraph (Gilson Medical Electronics Inc., Middleton, Wis-
consin). At 14 weeks in three PD rats, MAP obtained by the tail
artery needle method was compared to more conventional
measurements of MAP obtained after direct cannulation of the
left femoral artery in these rats during pentobarbital anesthesia.
Inulin clearance was also measured by conventional methods
[16] in these three rats to compare inulin clearance and creati-
nine clearance. Kidneys were also fixed by intra-aortic perfu-
sion of 1.25% gluteraldehyde in phosphate buffer, pH 7.4,
embedded in paraffin and examined by light microscopy.
Chemical analysis
Plasma and urine creatinine, and plasma and urine urea
nitrogen were measured by automated techniques using Beck-
man 2 Creatinine and Beckman 2 Urea Analyzer (Beckman
Instruments Inc., Fullerton, California, USA). Plasma choles-
terol and triglycerides were measured by enzymatic methods
[17, 18]; albumin was measured by a colorimetric method [19].
Urine, plasma sodium and potassium were measured by flame
photometry (Instrumentation Labs. Inc., Cidra, Puerto Rico).
Urinary osmolality (Uosm) was measured by an Advanced
Osmometer (Model 3R, Advanced Instruments Inc., Needham
Heights, Massachusetts, USA). Plasma and urine calcium were
measured by colonmetric orthocresolphthalein complexone[20]. Plasma and urine phosphorus were measured by
colorimetric phosphomolybdate [21]. Urine protein was mea-
sured by trichloroacetic acid precipitation methodology [22].
Kidney, heart and aorta calcium content were determined by
atomic absorption spectrophotometric methodology (Perkin-
Elmer Model 290B, Pasadena, California, USA) operated ac-
cording to the manufacturer's specifications [23]. Plasma and
urine inulin were determined by an autoanalyzer method.
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Table 1. Results of matching for both groups, prior to dietary
manipulation
PD Groupa PR Group P value
SCr, mg/deciliter 1.61 0.6 1.63 0.6 N5
Body weight, g 273 33 272 29 N5
Urine protein,
mg/day 235 125 279 145 N5
Serum cholesterol,
mg/deciliter 122 39 118 41 NS
Serum triglycerides,
mg/deciliter 169 79 180 93 N5
SCa2, mg/deciliter 10.4 0.2 10.6 0.5 NS
SN, mg/deciliter 7.0 0.4 6.7 1.3 N5
Abbreviations: SCr, serum creatinine; SCa2, serum calcium; SPi,
serum phosphorus
PD group would receive the phosphate binder dehydroxyaluminum
aminoacetate for the next 14 weeks. PR group would receive glycine for
the next 14 weeks.
= 9
Statistical analysis
Comparisons between PD and PR rats were made using
Student's unpaired t test and all results in the text and tables are
expressed as the mean 1 SD.
Results
Effect of 5/6 nephrectomy
The 5/6 nephrectomy resulted in significant changes in renal
function, Specifically, 5Cr increased from a pre-nephrectomy
value of 0.27 0.1 to 1.62 0.6 mg/dl, P <0.001 (N = 18).
Urine protein excretion also increased more than 10 times from
17.0 10.3 to 257.6 134.0 mg/day. Urine flow rate doubled
from 16.6 4.0 to 39.0 11.0 mL/day (P < 0.001) as did serum
cholesterol from 55.1 8.0 to 120.5 39.0 mg/deciliter (P <
0.001) and serum triglycerides from 93.5 22.0 to 174.4 83.0
mg/deciliter (P <0.001), Neither SCa2, which averaged 10.4
0.2 and 10.6 0.5 mg/deciliter, nor SPi, which averaged 7.0
0,4 and 6.7 1.3 mg/deciliter, were changed at 30 days after 5/6
nephrectomy (both P = NS).
Matching procedures
After ingesting a normal diet for 30 days, the 5/6 nephrecto-
mized rats were separated into two groups of nine rats each,
matched and paired by SCr and body weights. As shown in
Table 1, the average values for these two groups were not
different with respect to SCr, body weight, urine protein, serum
cholesterol, serum triglycerides, SCa2 or SP1.
Solute, urea, sodium and potassium excretion
A critical component of these studies concerns the documen-
tation of similar and normal levels of food intake between the
groups. In addition to daily examination of food consumption,
we also evaluated solute excretion (urine volume x UOsm)
each week in these rats. Solute excretion (mOsm/day) was
similar in both groups throughout the 14 weeks of this study
ranging from 22.0 4.0 to 30.0 8.0 mOsm/day (P NS).
Nitrogen balance was also evaluated in these rats to corrobo-
rate that each pair and each group in fact ingested similar
amounts of food. The results in Table 2 document that each
PD Group PR Group P value
At separation 190.0 45 155.4 98 N5
2nd week 52.7 75 50.0 53 N5
4th week 302.2 75 286.3 73 uS
6th week 313.8 89 288.0 78 N5
8th week 279.8 78 298.3 81 us
10th week 329.6 51 366.6 74 uS
12th week 259.6 43 247.4 105 us
14th week 325.6 38 200.2 47 <0.01
Fig. 2. 5/6 Nephrectomized rats consuming a normal protein diet
supplemented with DHA4A (closed circles) developed hypophospha-
temia whereas other rats consuming an identical diet supplemented
with glycine, the amino acid component of DHAAA), (open circles)
developed progressive hyperphosphatemia. Values are mean se. ', P
<0.001; P < 0.005; ***, P < 0.002.
group was comparable with respect to dietary food intake, as
assessed by biweekly nitrogen excretion during the first 12
weeks of the study. As a group the PR animals developed more
severe renal failure in the 14th week and the average urine urea
nitrogen excretion fell significantly at this time. This likely
resulted from the decrease in renal function since animals were
pairfed. The decrease in urea nitrogen excretion occurred rapidly
over a three day period concomitant with a precipitous decrease in
food consumption. All animals which developed symptoms of
terminal uremia prior to 14 weeks in this study also exhibited a
marked decrease in food intake which occurred quite rapidly over
two to three days. Sodium and potassium excretion were similar
during the 14 weeks of dietary manipulation between the PD and
PR rats and ranged from 0.9 to 1.3 mEq/day for sodium and from
2.7 to 3.7 mEq/day for potassium.
Effect of DHAAA on serum phosphorus and serum calcium
Rats with 5/6 nephrectomy ingesting a normal diet for 30 days
had normal levels of SPi as is shown in Figure 2. By the 6th
week of DHAAA, SPi decreased (2.85 0.8 vs. 6.71 1.2
mg/deciliter, P < 0.001). Thereafter, SPi remained low in
DHAAA treated group throughout the 14th week of study, but
Table 2. Urine urea excretion, mg/day
Diet
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Fig. 3. Phosphate deplete rats ingesting DHAAA (closed circles)
developed hypercalcemia in parallel with the decrease in serum phos-
phorus (Fig. 1). Phosphate replete rats ingesting glycine (open circles)
did not develop hypercalcemia. Values are mean SE. , P< 0.001; *
P < 0.002; ", P < 0.005.
by the 12th week the PR group demonstrated a significant
increase in SPi to 12.7 7.4 mg/deciliter as compared to the PD
group in which SPi averaged 3.6 0.7 mg/deciliter, P < 0.05.
SCa2 also increased in parallel with the decrease in SPi in the
PD group averaging 12.0 0.7 vs. 10.0 0.7 mg/deciliter in the
PR group, P < 0.001 at the 6th week. Subsequently, as is shown
in Figure 3, SCa remained elevated. Hypercalcemia and
hypophosphatemia in the PD group at six weeks were associ-
ated with hypercalciuria (7.26 2.9 vs. 1.08 0.8 mg/day) and
hypophosphaturia (61 0.35 vs. 6.26 2.97 mg/day), both P <
0.001.
Urine protein excretion
Although the rats in the PD and PR groups were very similar
with respect to the degree of proteinuria at 30 days after
nephrectomy and prior to the dietary manipulations, significant
decreases in protein excretion were noted in the PD group by
the sixth week (75.4 41.8 vs. 296 70.5 mg/day, P < 0.001).
Urinary protein excretion in the PD group remained persis-
tently below the increasing levels seen in the PR group through-
out the remainder of the 14 week study (Fig. 4). At the
termination of this study (14 weeks post-separation) urine
protein excretion averaged 68.1 53.9 and 428.5 151.9
mg/day, P < 0.005, in the PD and PR rats, respectively.
Serum cholesterol
Serum cholesterol increased significantly during the 30 day
period following 5/6 nephrectomy (control 55.05 8.1 vs.
nephrectomy 120.47 39.2 mg/deciliter, P <0.001). Serum
cholesterol continued to increase in the PR group and at six
weeks post-separation, the value in the PR group was signifi-
cantly greater than in the PD group (147.7 34.6 vs. 105.3
30.4 mg/deciliter, P < 0.05). Thereafter, serum cholesterol
remained constant in the PD group and continued to rise in the
PR group (Fig. 5). At 14 weeks, serum cholesterol averaged 100
19.8 mg/deciliter in the PD group and 174.6 55.0 in the PR
group, P < 0.05.
Serum triglycerides
5/6 Nephrectomy also resulted in a significant increase in
serum triglycerides by 30 days. Thereafter, serum triglycerides
remained relatively constant in the PD group but increased in
;'////////////% Normal '////////////////////////////////////////////i
0 I I I I
—4 —2 0 2 4 6 8 10 12 14
Time, weeks
Fig. 4. DHAAA treated rats (closed circles) demonstrated reversal of
the severe proteinuria of chronic renal failure whereas phosphate
replete rats (open circles) demonstrated increasing amounts of protein-
uria. Values are mean SE. ",P < 0.001; 'fl', P < 0.005.
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Fig. 5. A. DHAAA treated rats (closed circles) had less elevation in
serum cholesterol compared to normophosphatemic rats (open circles).
", P < 0.05; **, p < 0.025; P < 0.01. B DHAAA treated rats(closed circles) had decreased levels of serum triglycerides whereas
normophosphatemic rats (open circles) demonstrated increased serum
triglycerides. Values are mean s. , P < 0.05; **, P < 0.02.
the PR group. By the 10th week after separation, serum
triglycerides averaged 325.6 186 in the PR group and 113.8
50.9 mg/deciliter in the PD group, P < 0.05. This difference
persisted through the 14th wk of the study (Fig. 5).
Serum albumin and hematocrit
Serum albumin had decreased to 2.3 0.3 mg/deciliter, P <
0.001 30 days after 5/6 nephrectomy. Thereafter, serum albumin
remained remarkably constant and ranged between 2.20 0.4
and 2.82 0.2 g/deciliter, neither rising nor falling in either
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Time, weeks
Fig. 6. The progressive polyuria of chronic renal failure was delayed in
DHAAA treated rats (closed circles) compared to phosphate replete
rats (open circles). Values are mean SE. ", PC 0.05; PC 0.1;
P C 0.025.
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flg. 7. Serum creatinine (SCr) increased rapidly and progressively in
phosphate replete rats (open circles) between 10 and 14 weeks but
remained constant in rats consuming a DHAAA supplemented diet
(closed circles). Values are mean Sn. ", P C 0.025; , P C 0.05.
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Fig. 8. Creatinine clearance decreased rapidly at 12 and 14 weeks in
phosphate replete rats (open circles) but remained constant in rats
consuming DHAAA (closed circles). Values are mean SE. ', P C
0.001; a, P 0.005.
Serum creatinine and creatinine clearance
The elevated SCr observed at 30 days after 5/6 nephrectomy
remained relatively constant in both PD and PR groups through
the 10th week after separation. At the 12th and 14th week, 5Cr
increased significantly in the PR group (Fig. 7). Creatinine
clearance demonstrated a similar pattern to that of SCr, remain-
ing relatively constant through the 10th week in both groups. At
12 and 14 weeks, a deterioration in creatinine clearance was
seen in the PR groups but not in the PD groups (Fig. 8).
Comparison of inulin and creatinine clearances in three
DHAAA treated rats were similar at 14 weeks, averaging 345
143 and 529 110 p1/mm, respectively (NS).
Histologic studies
Phosphate depletion largely prevented the typical histological
findings of end—stage renal disease. Minimal to moderate inter-
stitial fibrosis or inflammation, tubular dilatation or atrophy was
present in kidneys from the PD group; moreover, the majority
of glomeruli showed no overt abnormalities (Fig. 9A). These
observations were in marked contrast to the typical picture of
end-stage renal disease seen at 14 weeks in the PR group,
manifested by a widespread interstitial fibrosis, massive tubular
dilatation, tubular atrophy and segmental glomerular sclerosis
(Fig. 9B). Eight percent of glomeruli of PD rats exhibited
segmental sclerotic lesions characterized by adhesions, capil-
lary collapse, mesangial sclerosis and occasional hylaninosis.
Similarly, tubulointerstitial changes varied from absent to focal
tubular dilatation with mild interstitial fibrosis. In contrast, 67%
of glomeruli of PR rats showed segmental or global sclerosis;
the segmental lesions occupied a larger proportion of the tuft
than similar lesions in the PD group. Tubulointerstitial changes
were also much more marked in the PR group, with greater
tubular dilatation involving a much higher proportion of the
tubules and more extensive interstitial fibrosis with foci of
chronic inflammation.
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group. Red blood cell volumes were not different between the
PR and PD groups during the initial eight weeks after separa-
tion. From the 10th to the 14th week, however, the PR group
developed a progressive and severe anemia, with a final hema-
tocrit (14 weeks) of 29.6 14.0 in the PR group vs. 54.4 5.0
vol% in the PD group (P < 0.02). Fecal occult blood was not
detectable during development of anemia between 10 and 14
weeks.
Urine Volume
Rats exhibited a polyuric response during the 30 day post-
nephrectomy period (16.6 4.4 vs. 39.2 11.7 mI/day, P C
0.001). Following separation into two groups, daily urine vol-
ume remained elevated in both groups through the 14 weeks of
study. At six weeks post-separation, however, urine volume
was higher in the PR group vs. the PD group (45.2 7.5 vs. 35.0
5.8 mllday, P c 0.05) and remained persistently higher in the
PR group throughout the 10th week. Between the 10th and 14th
week the urine volume in the PR group decreased toward the
constant values seen in the PD group (Fig. 6)
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Fig. 9. H and E stained. Intact glomeruli and tubules from phosphate deplete rats, A, are in sharp contrast with the sclerotic glomeruli, dilated
tubules and interstitial scarring seen in the kidney from the pair rats of the phosphate replete group, B. (x65)
Table 3. Body weight and mortality rate
Body weight, g PD Group PR Group P value
At separation 273.2 33 271.7 29 NS
2nd week 280.1 46 272.0 57 NS
4th week 250.0 50 266.5 34 NS
6th week 238.0 59 261.8 45 NS
8th week 260.0 43 271.6 52 NS
10th week 278.0 36 286.0 46 NS
12th week 277.0 32 272.0 51 NS
14th week 268.0 33 252.0 48 NS
Mortality Rate
At separation
to 4th week 3 3
6th week — —
8th week — —
10th week — I
12th week — 1
14th week — 2
Final survival 6 2
The survival rates in PD and PR groups were 66.67% and 22.22%,
respectively.
Body weight and survival rate
The body wt in both groups of rats were not significantly
different during the 14 weeks of study. The PR group did,
however, begin to lose weight, presumably due to uremia,
between the 12th and 14th weeks (Table 3). The survival rate
from both groups was not different in the first four week
post-separation (Table 3). Three animals from both groups died
nearly at the same time, and all six of these rats had SCr higher
than 2 mg/dl prior to dietary separation. Between the 10th and
14th week post-separation, four additional PR rats developed
terminal uremia as shown in Table 3. Thus, seven of nine rats
from the PR group developed terminal uremia during the 14
week study. In contrast, no animals of the PD group developed
signs of terminal uremia after the fourth week post-nephrect-
omy. The PD animals were, however, electively sacrificed on
the same day that their pair-PR rat became terminally ill in
order to obtain comparisons of tissue morphology and calcium
content between PR and PD animals.
Blood pressure
Tail artery blood pressures were similar throughout the study
as is shown in Figure 10. Only near the end of this study, when
the number of surviving pairs was small, did it appear that PR
rats may have had higher MPA than did PD rats. Measurement
of MAP in the femoral artery was similar to that obtained from
the tail artery (96 8 vs. 102 7 mmHg, respectively, N = 3,
P = NS).
Tissue Calcium Content
Calcium content of kidney, heart and aorta from eight normal
rats, and four pairs of rats with chronic renal failure was
measured. Calcium content of kidneys, heart and aorta from
eight normal rats averaged 0.94 0.09, 0.45 0.05 and 1.28
0.46 mmole/kg dry wt, respectively. In four PR rats, kidney,
heart and aorta calcium content was high, averaging 11.74
6.79, 2.23 1.56 and 11.21 15.5 mmole/kg dry wt, respec-
140
E 120
E
S
100(0(0
.! 80
St
60
0 2 4 6 8 10 12 14
Time, weeks
Fig. 10. Mean arterial pressure (MAP) measured in DHAAA treated
rats (closed circles) is similar to MAP measured in phosphate replete
rats (open circles). Normal values were obtained in six normal rats.
Values are mean sa.
Ti
664 Lumlertgul et at
tively. For each of these rats, the PD member of the pair had
lower values (P < .05) for kidney, heart and aorta calcium
content. Kidney, heart and aorta calcium content in the PD
animals averaged 5,17 5.09, 0.541 0.06 and 1.88 0.56
mmole/kg dry wt, respectively.
Discussion
In recent years it has been argued that the protective effects
of phosphate depletion in delaying the progression of chronic
renal failure may not be related to phosphate per se. Rather it
has been suggested that some event associated with the reduced
level of food intake, possibly reduced protein ingestion, may be
the primary cause of renal protection 124]. Previous experimen-
tal studies addressing this important question have been beset
with technical problems. Specifically, commercial low phos-
phate diets are not palatable to rats and daily food ingestion is
about 50% of normal 110, present studyl. Thus, these rats
consume less protein as well as less calories, electrolytes and
other nutrients than do control animals. In most nutritional
studies which have examined the effect of dietary manipulation
on progression of chronic renal disease, the amounts of food
consumed have not been reported and/or pair feeding studies
have not been performed. Thus, it has been impossible to
separate the protective effects related to phosphate depletion
from those due to reduced intake of protein, calories, electro-
lytes or other nutrients.
In the present study, the problems of the low phosphate diets
were circumvented by using a normal diet augmented with the
phosphate binding antacid (DHAAA). This approach was asso-
ciated with the development of hypophosphatemia without
evidence of poor food intake. In preliminary studies we found
that DHAAA was more effective than was aluminum hydroxide
in promoting hypophosphatemia (unpublished results).
DHAAA also has other advantages in that it is easily mixed
with normal rat chow which is then consumed in amounts
identical to those eaten by normal rats, and this facilitates the
performance of pair feeding experiments.
The present study investigated the effect of phosphate deple-
tion begun 30 days after 5/6 nephrectomy on progression of
chronic renal failure; this approach permitted selection of a
uniform population of rats with a range of renal impairment,
which on average was modest. Using this 30 day screening
procedure, nine pairs of rats with very similar degrees of renal
impairment, based on SCr concentration and similar body
weights, were matched and selected for study. One member of
each pair received the normal diet supplemented with glycine,
the amino acid component of DHAAA. The other member of
the pair was given an amount of the normal diet (supplemented
with DHAAA) equivalent to the amount of glycine supple-
mented diet which had been consumed the previous day by its
paired member.
Over the course of 14 weeks, rats ingesting the diet with
DHAAA demonstrated hypophosphaturia and hypophospha-
temia, thus confirming the effectiveness of DHAAA as an oral
phosphate binder. Administration of the glycine vehicle in the
control group was not associated with a fall in either urine or
plasma phosphorus. The net food consumption, body weight
and sodium, potassium and solute excretion in the two groups
were comparable over the 14 week duration of the study. The
phosphate deplete group, however, did not develop signs of
terminal uremia and survival was three times higher in this
group compared to the phosphate replete group. These findings
support the interpretation that the DHAAA-induced
hypophosphatemia, rather than restriction of protein, caloric or
other constituents of food, was the mediator of any attenuation
of the progression of chronic renal disease.
Functional and biochemical studies between six and 14 weeks
of observation consistently demonstrated a less severely im-
paired physiologic state in the phosphate-depleted rats com-
pared to the control rats. The urinary protein excretion in-
creased significantly only in the control group of phosphate
replete rats and actually decreased significantly in the rats
ingesting DHAAA. In parallel with the decrease in urinary
protein excretion in the phosphate restricted rats, the magni-
tude of the increase in hypercholesterolemia and hypertriglyc-
eridemia was also attenuated. Anemia did not develop and
progressive polyuria was also not observed in the phosphate
deplete rats. Most importantly, serum creatinine progressively
increased, and creatinine clearance progressively decreased in
phosphate replete, but not in the phosphate deplete, rats and
severe tissue calcification was much less evident in the phos-
phate deplete rats. Thus, phosphate restriction achieved by
ingestion of the phosphate binder. DHAAA, in the presence of
a normal protein intake prevents many of the progressive
metabolic and renal effects of chronic renal failure.
The mechanism for this protective effect of phosphate deple-
tion is unclear but there are several possibilities to be consid-
ered. First, phosphate depletion lessens tissue calcification
associated with progression of chronic renal failure. This ob-
servation is compatible with the in vitro results of Bone [25—271
which demonstrated that 45Ca influx into kidney cells could be
reduced if medium phosphate was lowered. Not only was 45Ca
influx decreased, but tissue Ca2 content decreased as well.
Moreover, cells preloaded with Ca2 exhibit faster efflux rates
and diminution in cellular Ca2 content when the normal
medium is suddenly changed to a phosphate-free medium [25].
These isolated renal cell studies were performed in the absence
of parathyroid hormone (PTH) thus indicating a PTH-indepen-
dent mechanism. This is particularly important since it has also
been demonstrated that PTH, in a dose dependent manner,
increases the exchangeable Ca2 influx rate and the size of the
exchangeable pool in cultured kidney cells [27, 28]. A reduction
in plasma PTH following phosphate restriction has been dem-
onstrated in vivo [29] and therefore in the present study it is
possible that hypophosphatemia with accompanying hypercal-
cemia, and presumably suppressed PTH [30], may have atten-
uated Ca2 entry into renal cells.
In the present study an elevated plasma Ca2 and
hypercalciuria were present in the phosphate deplete rats and
yet heart, aorta and kidney tissue calcificiation did not increase
to the same extent as the phosphate replete rats. As discussed
above, this may have been due to the low plasma phosphate and
suppressed PTH [29, 30]. There are several pathways whereby
increased cellular calcium concentrations in phosphate replete,
partially nephrectomized animals, may cause cell injury includ-
ing effects on cellular cytoskeleton, activation of phospholi-
pases, plasma membrane injury, and mitochondrial dysfunction
[31]. In experimental studies these events may be reduced in
severity or eliminated entirely if cytosolic Ca2 overload is
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prevented [31]. Thus, in the present study it is possible that
hypophosphatemia and presumably suppressed plasma PTH
prevented cellular injury by minimizing cellular calcium accu-
mulation and any consequences thereof. The chronic effects of
hypophosphatemia on cellular calcium content, however, must
remain speculative until direct measurements are performed.
Much attention has also been given to the possible role of
systemic hypertension [3] and glomerular hyperfiltration [5] in
the glomerular injury of chronic renal failure. In this regard, it
has been suggested that protein restriction protects against
glomerular injury by reducing nephron hyperfiltration [5]. In
most studies, protein restriction would be expected to be
associated with reduced phosphate intake [11]. It is thus possi-
ble that phosphate restriction with or without protein restriction
might decrease glomerular hyperfiltration and prevent glomer-
ular sclerosis and progression of chronic renal disease [32]. In
this regard, although protein restriction would seem to be the
most likely mediator of preventing glomerular hyperfiltration
[33], particularly in those studies where phosphate depletion
was avoided by supplementing casein containing diets with
phosphate [7], an additional effect of phosphate restriction
alone cannot be excluded. Micropuncture studies, in pair fed
rats with phosphate depletion or phosphate repletion will be
necessary to address this issue.
Another possible mechanism by which phosphate depletion
could lessen the severity of progressive renal injury is by
reducing the level of cellular energy metabolism. In this regard,
renal ablation is associated with increased renal Na-K ATPase
and progression of renal disease [34] and recent evidence
suggests that thyroidectomy decreases Na-K ATPase and ame-
liorates the progression of chronic renal failure [141. These
findings are compatible with the hypothesis that reduction in the
cellular work of transport may prevent the progressive injury
seen with chronic renal failure
Lastly, phosphate depletion attenuated the lipid abnormali-
ties associated with uremia. In the present study 30 days after
5/6 nephrectomy, both groups of rats showed a significant
increase in serum triglyceride and cholesterol concentrations.
By the sixth week post-separation, phosphate depletion ar-
rested the rise in cholesterol and a significantly lower serum
cholesterol was observed in phosphate deplete as compared to
phosphate replete rats. Serum triglycerides were also lower in
the phosphate deplete rats after the 10th week. These results
could be explained by an attenuation of the degree of protein-
uria and a secondary amelioration of the altered serum choles-
terol and triglycerides. Alternatively, a recovery of activity for
both peripheral and hepatic triglyceride lipases, as well as an
increase in the concentration of high density lipoprotein may
have occurred. Since parathyroidectomy does not prevent
hypertriglyceridemia in the nephrotoxic serum nephritis model
[14], it seems less likely that parathyroid hormone is involved.
Lipoprotein has been proposed to be a pathogenic factor in
the development of glomerulonephritis. An increase in lipid
content of glomerular basement membrane in rats with nephritis
has been shown to occur prior to leukocyte infiltration [35, 36].
Presumably, lipoprotein could penetrate the glomerular endo-
thelium and accumulate in the mesangial cells which eventually
proliferate and become sclerotic. Phosphate depletion, there-
fore, could increase lipoprotein lipase and/or reduce the abnor-
mal glomerular basement membrane permeability and diminish
the penetration of lipoprotein through the glomerular endothe-
hum. This might decrease mesangial proliferation and result in
diminished glomerular sclerosis. Lipoprotein was not measured
in the present study; serum albumin, however, did not differ
between phosphate deplete and phosphate replete rats.
Finally, the DHAAA treated rats consumed aluminum which
was not ingested in the rats consuming glycine. The indepen-
dent effect of aluminum on preventing the progression of
chronic renal failure was not addressed in this study, however,
in other tissues aluminum has been found to be deleterious, not
beneficial.
There are some other important considerations to be noted
from the results of the present study. The rats which had a SCr
higher than 2 mg/deciliter prior to separation died during the
first four week post-separation irrespective of dietary intake. In
contrast, all phosphate depleted rats which had a SCr lower
than 2 mg/deciliter at separation, exhibited protection against
the progressive renal failure of the remnant kidney model.
Overall survival rate for the rats in the phosphate depleted
group was much better than the phosphate repleted group
(66.67% vs. 22.22%, P < 0.05). These observations suggest that
if the dietary manipulation of phosphate is commenced after the
kidney has been profoundly damaged (i.e., when SCr is above
2 mg/deciliter), amelioration of the progressive course of
chronic renal failure may be unsuccessful. This interpretation is
consistent with that made by Barrientos et al who could not
demonstrate any amelioration of the rate of renal functional
deterioration when phosphate restriction was initiated in pa-
tients whose renal injury was already severe (i.e., serum
creatinine greater than 5 mg/deciliter) [37]. It is also consistent
with the recent observations of Barsotti et al who demonstrated
that renal functional deterioration could be halted in patients
fed a very low phosphate and a low nitrogen diet whereas low
nitrogen and moderate phosphate restriction was not as bene-
ficial [38]. These results therefore suggest that early interven-
tion with dietary manipulation of serum phosphate may be
associated with impressive functional and biochemical evidence
of protection against progression of chronic renal failure.
In summary, in a partially nephrectomized experimental
model of chronic renal failure, two groups of rats which had
comparable degrees of renal dysfunction were meticulously pair
fed in order to assure identical and normal quantities of food
consumption. Phosphate depletion was demonstrated to exert
functional, biochemical and structural protection against the
progression of chronic renal failure. The survival rate in the
phosphate deplete group was also better than in the phosphate
replete group. Phosphate restriction was associated with ame-
lioration of the 1) progressive uremia, 2) lipid abnormalities, 3)
renal functional deterioration, 4) proteinuria, and 5) nephrocal-
cinosis associated with this experimental model of chronic renal
failure. The most impressive results were obtained when phos••
phate restriction was initiated prior to a rise in serum creatinine
above 2 mg/deciliter. The potential multifactorial mechanisms
of protection afforded by phosphate restriction have been
discussed, but it is important to note that either protein restric-
tion alone [12], phosphate restriction alone (present study) or
some combination thereof [3—5, 38] may delay the progression
of chronic renal failure in both animals and man.
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